HC Wainwright & Co. Reiterates Buy on Aridis Pharmaceuticals, Maintains $2 Price Target
Aridis Pharmaceuticals Analyst Ratings
Promising Developments and Value Proposition: A Buy Rating Analysis of Aridis Pharmaceuticals
Aridis Pharmaceuticals Analyst Ratings
Maxim Group Sticks to Its Hold Rating for Aridis Pharmaceuticals (ARDS)
Analysts Offer Insights on Healthcare Companies: Ocuphire Pharma (OCUP), Aridis Pharmaceuticals (ARDS) and Acurx Pharmaceuticals (ACXP)
Aridis Pharmaceuticals Analyst Ratings
HC Wainwright & Co. Maintains Buy on Aridis Pharmaceuticals, Lowers Price Target to $10
Aridis Pharmaceuticals (ARDS) Gets a Buy From H.C. Wainwright
Analysts' Top Healthcare Picks: Aridis Pharmaceuticals (ARDS), Minerva Neurosciences (NERV)
Aridis Pharmaceuticals Cut to Hold From Buy by Maxim Group
Aridis Pharmaceuticals Analyst Ratings
No Data